肠道来源T细胞异常肝内迁移并非原发性硬化性胆管炎特有
本研究通过分析接受肝移植的慢性肝病患者及正常肝组织,评估肠道归巢分子在肝脏的表达及肠道来源T细胞的浸润情况。结果发现这些分子的上调及特定T细胞频率增加在所有慢性肝病中均存在,并非原发性硬化性胆管炎独有,从而反驳了「肠道归巢」假说作为该病主要驱动因素的观点。
要点
- 肠道归巢分子在多种慢性肝病肝组织中均上调,组间无差异。
- 表达α4β7、αEβ7、CCR9、GPR15的肝内T细胞频率在慢性肝病中普遍增加。
- β7阳性肝T细胞呈现促炎表型,但该表型也见于正常肝脏。
核心结论
- 肠道来源T细胞的异常肝内招募并非原发性硬化性胆管炎特有,而是所有病因慢性肝病的共同特征。
研究设计与样本
- 对接受肝移植的慢性肝病患者及正常肝组织进行组织学、RT-PCR和流式细胞术分析。
主要发现
- MAdCAM-1、CCL25和E-Cadherin在全部慢性肝病肝组织中表达上调,且疾病组间无差异。
- 表达α4β7、αEβ7、CCR9和GPR15的肝内T细胞频率在PSC-IBD及疾病对照组中均高于正常肝脏。
- β7阳性肝T细胞呈现更明显的炎症表型,但该表型在炎症及正常肝脏中均存在。
临床怎么用
- 提示针对肠道归巢通路的治疗策略可能不具PSC特异性,需考虑其在慢性肝病中的普遍性。
局限性
- 研究基于接受肝移植患者的离体肝组织,可能代表疾病终末期,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The "gut homing" hypothesis suggests the pathogenesis of primary sclerosing cholangitis (PSC) is driven by aberrant hepatic expression of gut adhesion molecules and subsequent recruitment of gut-derived T cells to the liver. However, inconsistencies lie within this theory including an absence of investigations and comparisons with other chronic liver diseases (CLD). Here, we examine "the gut homing theory" in patients with PSC with associated inflammatory bowel disease (PSC-IBD) and across multiple inflammatory liver diseases. APPROACH AND RESULTS: Expression of MAdCAM-1, CCL25, and E-Cadherin were assessed histologically and using RT-PCR on explanted liver tissue from patients with CLD undergoing OLT and in normal liver. Liver mononuclear cells were isolated from explanted tissue samples and the expression of gut homing integrins and cytokines on hepatic infiltrating gut-derived T cells was assessed using flow cytometry. Hepatic expression of MAdCAM-1, CCL25 and E-Cadherin was up-regulated in all CLDs compared with normal liver. There were no differences between disease groups. Frequencies of α4β7, αEβ7, CCR9, and GPR15 expressing hepatic T cells was increased in PSC-IBD, but also in CLD controls, compared with normal liver. β7 expressing hepatic T cells displayed an increased inflammatory phenotype compared with β7 negative cells, although this inflammatory cytokine profile was present in both the inflamed and normal liver. CONCLUSIONS: These findings refute the widely accepted "gut homing" hypothesis as the primary driver of PSC and indicate that aberrant hepatic recruitment of gut-derived T cells is not unique to PSC, but is a panetiological feature of CLD.
引用
- Graham JJ, Mukherjee S, Yuksel M, et al. Aberrant hepatic trafficking of gut-derived T cells is not specific to primary sclerosing cholangitis. Hepatology. 2021. PMID: 34633679. doi:10.1002/hep.32193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。